Job/Unit: O42821
/KAP1
Date: 20-11-14 13:05:28
Pages: 6
G. Gros, J. Hasserodt
FULL PAPER
369 mmol) was added, and the mixture was again heated at 50 °C
for 2 h. The solvent was removed under reduced pressure, and
NaOH (1 m solution, 250 mL) was added to the residue. The mix-
ture was extracted with DCM (3ϫ 250 mL). The combined organic
phases were washed with NaOH (1 m solution, 250 mL), dried with
Na2SO4, and filtered.
General Procedure C – Formation of the 4-Alkylated 1,7-Bis(alkyl-
ated) Octahydroimidazo[1,2-a]pyrazin-4-ium Halide: The alkylating
agent (1 equiv.) was added to a vigorously stirred mixture of 1,7-
bis(alkylated) octahydroimidazo[1,2-a]pyrazine (1 equiv.) and
K2CO3 (2 equiv.) in MeCN (5 mL/mmol). The reaction was stirred
for 18 h, and then the salt was removed by filtration through a pad
of Celite. The solvent was removed under reduced pressure, and
the residue was dissolved in a minimum amount of DCM. The
DCM solution was added dropwise to a large volume of diethyl
ether (20 mL/mmol). The resulting hygroscopic precipitate was fil-
tered through a sintered glass funnel and washed with diethyl ether.
An additional crop of product could be obtained by applying this
procedure to the residue that was obtained by concentrating the
filtrate to dryness.
1,7-Dibenzyldiethylenetriamine Tris(hydrochloride) (4a): The com-
pound was synthesized by employing benzaldehyde and following
procedure A. The DCM solution was concentrated to half its vol-
ume and then treated with concentrated HCl (12.5 mL, 37%). The
resulting precipitate was filtered through a sintered glass funnel and
then washed with DCM and diethyl ether to give 4a (17.2 g, 95%
1
yield) as a colorless powder. H NMR (300 MHz, D2O): δ = 7.44
(m, 10 H), 4.26 (s, 4 H), 3.38 (s, 8 H) ppm. MS (ESI): m/z = 284.2
[M + H]+.
4-(2-Ethoxy-2-oxoethyl)-1,7-dibenzyloctahydroimidazo[1,2-a]pyr-
azin-4-ium Bromide (6b): Employing compound 5a (308 mg,
1.0 mmol) and ethyl bromoacetate and following procedure C af-
forded compound 6b (219 mg, 46 % yield) as a yellowish oil.
HRMS (ESI): calcd. for C24H32N3O2 [M]+ 394.2489; found
394.2499.
1,7-Bis(pyridin-2-ylmethyl)diethylenetriamine (4c): The compound
was synthesized by employing 2-pyridinecarbaldehyde and follow-
ing procedure A. After the DCM solution was dried with Na2SO4
and filtered, the solvent was removed under reduced pressure to
give 4c (11.4 g, 92% yield) as a reddish oil. 1H NMR (300 MHz,
CDCl3): δ = 8.52 (d, 1 H), 8.43 (d, 1 H), 7.60 (m, 2 H), 7.49 (d, 1
H), 7.35 (d, 1 H), 7.11 (m, 2 H), 3.98 (d, 1 H), 3.71 (s, 2 H), 3.61
(d, 1 H), 3.25 (m, 1 H), 3.12 (m, 1 H), 2.99–2.87 (m, 3 H), 2.75 (d,
1 H), 2.53–2.41 (m, 4 H), 2.13 (t, 1 H) ppm. 13C NMR (76 MHz,
CDCl3): δ = 159.6, 158.3, 149.2, 148.7, 136.4 (d), 123.2, 122.7,
122.0, 121.9, 81.3, 64.3, 56.7, 52.0, 51.4, 50.4, 50.0 ppm. HRMS
(ESI): calcd. for C18H24N5 [M + H]+ 310.2026; found 310.2012.
4-(4-Methoxybenzyl)-1,7-bis(pyridin-2-ylmethyl)octahydroimidazo-
[1,2-a]pyrazin-4-ium Chloride (6g): Employing compound 5c
(6.10 g, 19.7 mmol) and 4-methoxybenzyl chloride and following
procedure C afforded compound 6g (6.89 g, 75% yield) as a yellow-
ish oil. HRMS (ESI): calcd. for C26H32N5O [M]+ 430.2601; found
430.2582.
General Procedure D – Macrocycle Opening by Using NaBH4:
NaBH4 (2 equiv.) was added in small portions to a solution of the
4-alkylated-1,7-bis(alkylated) octahydroimidazo[1,2-a]pyrazin-4-
ium halide (1 equiv.) in absolute EtOH (10 mL/mmol) at room
temp. The reaction was stirred for 10–15 min and monitored by
MS. The solvent was then removed under reduced pressure to give
a residue that was dissolved in NaOH (1 m aqueous solution,
10 mL/mmol). The resulting solution was extracted with DCM
(3ϫ10 mL/mmol), and the combined organic phases were washed
with NaOH (1 m aqueous solution, 10 mL/mmol), dried with
Na2SO4, and filtered. The solvent was removed under reduced pres-
sure to give the ring-opened product.
General Procedure B – Formation of the 1,7-Bis(alkylated) Octa-
hydroimidazo[1,2-a]pyrazine:
A solution of chloroacetaldehyde
(45% w/w in water, 1 equiv.) in MeCN (5 mL/mmol) was added
dropwise to a solution of the 1,7-bis(alkylated) diethylenetriamine
(1 equiv.) and K2CO3 (2 equiv.) in MeCN (5 mL/mmol) as the mix-
ture was vigorously stirred. The reaction was stirred for 4 h, and
then the salt was removed by filtration through a pad of Celite.
The solvent was removed under reduced pressure, and the residue
was dissolved in a minimum amount of DCM. The DCM solution
was added dropwise to a large volume of ether (20 mL/mmol). The
mixture was filtered through a sintered glass funnel, and the filtrate
was concentrated under reduced pressure to give the desired prod-
uct. The purification of the recovered solid/oily phase was repeated
if necessary.
4-(4-Methoxybenzyl)-1,7-bis(pyridin-2-ylmethyl)-1,4,7-triazacyclo-
nonane (3g): Employing compound 6g (2.54 g, 5.45 mmol) and fol-
lowing procedure D afforded compound 3g (1.78 g, 76% yield) as
a yellowish oil. 1H NMR (300 MHz, CDCl3): δ = 8.52 (d, 2 H),
7.65 (t, 2 H), 7.52 (d, 2 H), 7.25 (d, 2 H), 7.14 (t, 2 H), 6.84 (d, 2
H), 3.83 (s, 3 H), 3.80 (s, 4 H), 3.56 (s, 2 H), 2.93 (s, 4 H), 2.87 (m,
4 H), 2.78 (m, 4 H) ppm. 13C NMR (76 MHz, CDCl3): δ = 160.7,
158.4, 148.9, 136.2, 132.3, 130.1, 123.2, 121.7, 113.7, 64.7, 62.6,
55.7 (d), 55.6, 55.2 ppm. HRMS (ESI): calcd. for C26H34N5O [M
+ H]+ 432.2756; found 432.2739.
1,7-Dibenzyloctahydroimidazo[1,2-a]pyrazine (5a): Employing the
neutral form of compound 4a (822 mg, 2.90 mmol) and following
procedure B afforded compound 5a (810 mg, 91% yield) as a yel-
1
lowish oil. H NMR (300 MHz, CDCl3): δ = 7.46 (m, 10 H), 4.02
(d, 1 H), 3.71 (s, 2 H), 3.63 (d, 1 H), 3.25 (m, 1 H), 3.12 (m, 1 H),
2.99–2.87 (m, 3 H), 2.75 (d, 1 H), 2.53–2.41 (m, 4 H), 2.13 (t, 1
H) ppm. 13C NMR (76 MHz, CDCl3): δ = 163.3, 139.3, 138.1,
129.2 128.5, 128.2, 128.2, 127.0, 126.9, 81.5, 65.9, 62.9, 57.8, 56.7,
51.9, 51.2 ppm. HRMS (ESI): calcd. for C20H26N5 [M + H]+
308.2121; found 308.2108.
General Procedure E – Bicycle Opening by Using NaBH(OAc)3:
NaBH(OAc)3 (2 equiv.) was added in small portions to a solution
of the 4-alkylated 1,7-bis(alkylated) octahydroimidazo[1,2-a]pyr-
azin-4-ium halide (1 equiv.) in DCM (10 mL per mmol) at room
temp. The mixture was stirred for 1–2 h, and the progress was mon-
itored by MS. The reaction was quenched by the addition of NaOH
(1 m aqueous solution, 10 mL/mmol), and the resulting mixture was
extracted with DCM (3ϫ10 mL/mmol). The organic phases were
combined, washed with NaOH (1 m solution, 10 mL/mmol), dried
with Na2SO4, and filtered. The solvent was removed under reduced
pressure to give the ring-opened product.
1,7-Bis(pyridin-2-ylmethyl)octahydroimidazo[1,2-a]pyrazine
(5c):
Employing compound 4c (11.4 g, 40.0 mmol) and following pro-
cedure B afforded compound 5c (10.31 g, 84% yield) as a yellowish
1
oil. H NMR (300 MHz, CDCl3): δ = 8.52 (d, 1 H), 8.43 (d, 1 H),
7.60 (m, 2 H), 7.49 (d, 1 H), 7.35 (d, 1 H), 7.11 (m, 2 H), 3.98 (d,
1 H), 3.71 (s, 2 H), 3.61 (d, 1 H), 3.25 (m, 1 H), 3.12 (m, 1 H),
2.99–2.87 (m, 3 H), 2.75 (d, 1 H), 2.53–2.41 (m, 4 H), 2.13 (t, 1
H) ppm. 13C NMR (76 MHz, CDCl3): δ = 159.6, 158.3, 149.2,
148.7, 136.4 (d), 123.2, 122.7, 122.0, 121.9, 81.3, 64.3, 56.7, 52.0,
51.4, 50.4, 50.0 ppm. HRMS (ESI): calcd. for C18H24N5 [M + H]+
310.2026; found 310.2012.
4-(2-Ethoxy-2-oxoethyl)-1,7-dibenzyl-1,4,7-triazacyclononane (3b):
Employing compound 6b (220 mg, 0.46 mmol) and following pro-
4
www.eurjoc.org
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 0000, 0–0